Silicon Investor
SI
SI

 Biotech / Medical : Incyte Pharmaceuticals (INCY) -- Ignore unavailable to you. Want to Upgrade?


To: quantman who wrote (2657)5/11/2011 10:50:09 AM
From: BiomavenRead Replies (1) | Respond to of 2872
 
>>potentially be a registrational trial

Well at that point the drug would already be on the market, so safety would not be an issue. If they showed a survival benefit (which would be the first ever in this indication) I can't see the FDA quibbling.

Peter


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise
Copyright © 1995-2013 Knight Sac Media. All rights reserved.